Camelot Portfolios’s Madison Square Garden MSGS Stock Holding History
Bought
Maintained
Sold
Other funds holding MSGS
SLG
AI
GI
Camelot Portfolios's MSGS Position: Q1 2026 in Review
Camelot Portfolios sold out of Madison Square Garden (MSGS) in Q1 2026, closing a stake of 500 shares — an estimated $129K sold.
Camelot Portfolios first reported a position in MSGS in Q2 2024 and held it in 2 quarters. The position peaked at $129K in Q4 2025. 410 funds tracked by Wall St. Rank hold MSGS as of Q1 2026.
- Camelot Portfolios reported no remaining Madison Square Garden position as of Q1 2026 after selling out during the quarter.
- Camelot Portfolios sold 500 Madison Square Garden shares in Q1 2026, an estimated $129K.
- Camelot Portfolios first reported a position in Madison Square Garden in Q2 2024 and held it in 2 quarters.
- Camelot Portfolios's Madison Square Garden position peaked at $129K in Q4 2025.
- 410 funds tracked by Wall St. Rank held Madison Square Garden as of Q1 2026.
Based on Camelot Portfolios's 13F filing for Q1 2026, filed 8 May 2026.